APRIL 23, 2007 BIO-QUANT, INC. relocates headquaters. New Site Features State-of-the-Art Drug Development and Contract Research Facility and Corporate Offices.
  MAY 12, 2005 Argus Health Products Licenses Bio-Quant’s Topical Analgesic Products for The USA and Canada
  DECEMBER 3, 2003Argus Health Products Obtains the Rights to Bio-Quant Antimicrobial Line of Products

  APRIL 28, 2003Bio-Quant Awarded the Department of Defense Sponsored -SPAWAR- Center for Commercialization of Advanced Technology -CCAT- Grant

  JULY 30 , 2002Bio-Quant, Inc. expands its natural product chemical library size and diversity through alliance with MolecularNature Ltd.

  JANUARY 30 , 2002Bio-Quant awarded the department of defense sponsored -SPAWAR- center for commercialization of advanced technology -CCAT- grant.

  DECEMBER 10 , 2001 DOMPE and Bio-Quant form new drug discovery collaboration.

  OCTOBER 29 , 2001 Bio-Quant represents the Private Sector in the Last California Liaison Congressional Scientific Committee.

  OCTOBER 2 , 2001Bio-Quant and TEF LABS sign agreement to jointly develop novel fluorescent dyes for use in high Throughput Screening.

  SEPTEMBER 5 , 2001Bio-Quant Creates new GPCR Screening division.

  MARCH 27, 2001Bio-Quant, Inc. names Bassam B. Damaj, Ph. D., President and CEO.

  MARCH 27, 2001Bio-Quant, Inc. relocates headquarters to San Diego.


You may use this form to subscribe to The Bio Quant Press Releases.
Fields marked with a red asterisk (*) are required.

First name Last name
Email* 
Address  City  
State  Zip   
Country*   

To Unsubscribe :      Click here